Takeda Pharmaceutical
TAK
#489
Rank
A$71.37 B
Marketcap
A$21.45
Share price
0.28%
Change (1 day)
2.21%
Change (1 year)

Takeda Pharmaceutical (TAK) - Total debt

Total debt on the balance sheet as of September 2025 : A$47.34 Billion

According to Takeda Pharmaceutical's latest financial reports the company's total debt is A$47.34 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Takeda Pharmaceutical - Total debt on balance sheet (from 2008 to 2025)

Total debt by year

Year Total debt Change
2025-03-31A$48.25 B-1.47%
2024-03-31A$48.97 B-0.2%
2023-03-31A$49.07 B3.01%
2022-03-31A$47.63 B-13.57%
2021-03-31A$55.11 B-28.61%
2020-03-31A$77.19 B5.99%
2019-03-31A$72.83 B503.55%
2018-03-31A$12.06 B-10.33%
2017-03-31A$13.45 B51.13%
2016-03-31A$8.90 B11.57%
2015-03-31A$7.98 B-11.21%
2014-03-31A$8.98 B50.96%
2013-03-31A$5.95 B-5.55%
2012-03-31A$6.30 B2547.45%
2011-03-31A$0.23 B9.43%
2010-03-31A$0.21 B-24.06%
2009-03-31A$0.28 B703.34%
2008-03-31A$35.67 M-70.78%
2007-03-31A$0.12 B-19.33%
2006-03-31A$0.15 B-31.94%
2005-03-31A$0.22 B18.75%
2004-03-31A$0.18 B5.99%
2003-03-31A$0.17 B-19.61%
2002-03-31A$0.21 B-16.44%
2001-03-31A$0.26 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
A$69.07 B 45.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$38.51 B-18.66%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
A$91.78 B 93.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$48.30 B 2.02%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Seagen
SGEN
A$0.17 B-99.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
A$0.99 B-97.90%๐Ÿ‡ฎ๐Ÿ‡ณ India
Amgen
AMGN
A$82.33 B 73.91%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$35.99 B-23.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
A$62.40 B 31.82%๐Ÿ‡บ๐Ÿ‡ธ USA